Press Releases

Steven Nurkin, MD, led research on “watch and wait” strategy for rectal cancer.

“Watch and Wait” Strategy Puts Surgery On Hold for Some With Rectal Cancer

Tuesday, March 26, 2019
Imagine not having to think about surgery as part of cancer care. Researchers at Roswell Park Comprehensive Cancer Center are seeing encouraging results with a group of rectal cancer patients who were able to safely defer surgery rather than going under the knife.

Roswell Park Becomes First Site in New York Accredited to Provide Tobacco Treatment Specialist Training

Workshops set for April, July and October 2019
Monday, March 25, 2019
Registration is open for Tobacco Treatment Specialist Training Workshops presented by the Department of Health Behavior at Roswell Park Comprehensive Cancer Center.

Chief Technology Officer Role Created to Enhance Patient-Centric Tech Solutions at Roswell Park

Paul Visco moves into new role after 15 years with cancer center
Wednesday, March 20, 2019
Paul Visco has been promoted to the role of Chief Technology Officer at Roswell Park Comprehensive Cancer Center.

Roswell Park Researchers Take Center Stage at Meeting of Experts on Gynecologic Cancers

Friday, March 15, 2019
Members of Roswell Park Comprehensive Cancer Center’s senior leadership team, physician staff and fellows have been invited to present research findings and insights at the Society of Gynecologic Oncology (SGO) 50th Annual Meeting on Women’s Cancer. SGO is considered the premier specialty society for healthcare professionals focused on comprehensive treatment of gynecological cancers. The meeting runs March 16-19 in Honolulu, Hawaii.

Physician Executive Will Lead Value-Based Care Initiatives at Roswell Park

Wednesday, March 13, 2019
Raghu Ram, MD, has joined Roswell Park Comprehensive Cancer Center as Vice President of Value-Based Care Optimization and Community Clinical Collaboration. Dr. Ram started in his new role on March 4.

Roswell Park Attracts $28.2M in Grants, Including $9.7M for Studies of Breast Cancer in African-Americans

Thursday, March 7, 2019
A $6.6 million award from the National Cancer Institute (NCI) leads the latest slew of grants awarded to Roswell Park Comprehensive Cancer Center researchers. These awards totaling more than $28.2 million in new funding from federal agencies as well as nonprofit foundations and associations will enable critical investigations to help explain why an aggressive form of breast cancer is more common in African-American women, learn how cancer metastasizes and develops resistance to treatment, explore opportunities to enhance patients’ recovery following surgery and advance development of a pioneering immunotherapy involving engineered T cells.

Roswell Park Workforce Swells to Record Level With Latest Slate of Hires and Promotions

Wednesday, February 27, 2019
The team at Roswell Park Comprehensive Cancer Center has reached record levels, growing to a workforce of more than 3,500. The latest appointments announced by Roswell Park President and CEO Candace S. Johnson, PhD, and her senior leadership team mark a milestone for the 121-year-old cancer center, reflecting expansion across all areas of operations, from clinical care and education to new frontiers in cancer research.

Roswell Park Presentations at TCT 2019 Focus on Tools for Predicting Patient Outcomes

Thursday, February 21, 2019
Particularly in the realm of cancer care, which can mean years of treatment and follow-up for patients, clinicians look to a number of tools and metrics to guide their decision-making regarding what, if any, treatment options and care approaches may be most effective for a particular patient. Roswell Park Comprehensive Cancer Center experts were invited to highlight ways to optimize these predictive strategies to improve both treatment and rehabilitation of patients undergoing hematopoietic stem cell transplantation, also known as bone marrow transplant, during the TCT/Transplantation and Cellular Therapy Meetings now underway in Houston, Texas.

Roswell Park Researchers Identify Protein That Contributes to Racial Disparities in Prostate Cancer

Thursday, February 14, 2019
Cancer researchers have long known that prostate cancer tends to be more common, more aggressive and more resistant to existing treatments in African-Americans than in Caucasian-Americans, but they’re only beginning to understand why. A Roswell Park Comprehensive Cancer Center study published today points to cellular factors that appear to be driving these disparities — mitochondrial differences that prevent formation of the cancer-killing “death wheel” apoptosome protein complex — and proposes a strategy for overcoming these factors with new therapeutic targets.

Roswell Park Reports New Path to Overcoming Drug Resistance in HER2-Positive Breast Cancer

Tuesday, February 12, 2019
The HER2 protein, which encourages the growth of cancer cells, is present in about 20% of all breast cancers. While HER2-positive breast cancers tend to be very aggressive, today the prognosis is generally very good, thanks to the introduction of HER2 inhibitors such as trastuzumab (brand name Herceptin). However, not all HER2-positive breast cancers respond to existing HER2 inhibitors.

Roswell Park, NFMMC Launch Cancer Care Collaboration

Friday, February 8, 2019
Roswell Park Comprehensive Cancer Center and Niagara Falls Memorial Medical Center today announced a collaborative effort to greatly improve the availability of cancer care in Niagara County. The first step of the new collaborative partnership is a comprehensive thoracic clinical program.

Genetic and Metabolic Differences May Help Explain Inconsistencies in Studies on Diet and Cancer

Tuesday, February 5, 2019
While research suggests that increasing dietary intake of lignans — nutrients found in whole grains, vegetables, fruits and seeds — may reduce risk of breast cancer, the findings from studies testing this hypothesis have been inconsistent. A new study from Roswell Park Comprehensive Cancer Center, published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association of Cancer Research (AACR), examines how women of different backgrounds metabolize lignans. What these scientists learned may help explain why associations between diet and breast cancer risk have been difficult to demonstrate consistently.